Advertisement

Addressing PRES and RCVS: Two distinct entities or a spectrum of the same disease?

      Dear editor,
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Stroke and Cerebrovascular Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Jeanneret V.
        • Jillella D.V.
        • Rangaraju S.
        • Groover O.
        • Peterson R.
        • Koneru S.
        • Nahab F.
        • Kase C.S.
        PRES and RCVS: two distinct entities or a spectrum of the same disease?.
        J Stroke Cerebrovasc Dis. 2022; 31106472https://doi.org/10.1016/J.JSTROKECEREBROVASDIS.2022.106472
        • Fugate J.E.
        • Rabinstein A.A.
        Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions.
        Lancet Neurol. 2015; 14: 914-925https://doi.org/10.1016/S1474-4422(15)00111-8
        • Ducros A.
        Reversible cerebral vasoconstriction syndrome.
        Lancet Neurol. 2012; 11: 906-917https://doi.org/10.1016/S1474-4422(12)70135-7
        • Pilato F.
        • Distefano M.
        • Calandrelli R.
        Posterior Reversible encephalopathy syndrome and reversible cerebral vasoconstriction syndrome: clinical and radiological considerations.
        Front Neurol. 2020; 11: 34https://doi.org/10.3389/FNEUR.2020.00034/BIBTEX
        • Chen H.
        • Xu Z.
        • Yuan Y.
        Posterior reversible encephalopathy syndrome and reversible cerebral vasoconstriction syndrome associated spinal subdural hematoma: A case report.
        Medicine. 2020; 99: e21522https://doi.org/10.1097/MD.0000000000021522
        • Varga Z.
        • Flammer A.J.
        • Steiger P.
        • Haberecker M.
        • Andermatt R.
        • Zinkernagel A.S.
        • Mehra M.R.
        • Schuepbach R.A.
        • Ruschitzka F.
        • Moch H.
        Endothelial cell infection and endotheliitis in COVID-19.
        Lancet. 2020; 395: 1417-1418
        • Kichloo A.
        • Dettloff K.
        • Aljadah M.
        • Albosta M.
        • Jamal S.
        • Singh J.
        • Wani F.
        • Kumar A.
        • Vallabhaneni S.
        • Khan M.Z.
        COVID-19 and hypercoagulability: a review.
        Clin Appl Thromb. 2020; 26
        • Williams O.H.
        • Mohideen S.
        • Sen A.
        • Martinovic O.
        • Hart J.
        • Brex P.A.
        • Sztriha L.K.
        Multiple internal border zone infarcts in a patient with COVID-19 and CADASIL.
        J Neurol Sci. 2020; 416
        • Cruciani A.
        • Pilato F.
        • Rossi M.
        • Motolese F.
        • Di Lazzaro V.
        • Capone F.
        Ischemic stroke in a patient with stable CADASIL during COVID-19: A CASE Report.
        Brain Sci. 2021; 11https://doi.org/10.3390/BRAINSCI11121615
        • Bonaventura A.
        • Vecchié A.
        • Dagna L.
        • Martinod K.
        • Dixon D.L.
        • Van Tassell B.W.
        • Dentali F.
        • Montecucco F.
        • Massberg S.
        • Levi M.
        • et al.
        Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19.
        Nat Rev Immunol 2021 215. 2021; 21: 319-329https://doi.org/10.1038/s41577-021-00536-9
        • Krasemann S.
        • Haferkamp U.
        • Pfefferle S.
        • Woo M.S.
        • Heinrich F.
        • Schweizer M.
        • Appelt-Menzel A.
        • Cubukova A.
        • Barenberg J.
        • Leu J.
        • et al.
        The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2.
        Stem Cell Reports. 2022; 17: 307-320https://doi.org/10.1016/J.STEMCR.2021.12.011
        • Motolese F.
        • Ferrante M.
        • Rossi M.
        • Magliozzi A.
        • Sbarra M.
        • Ursini F.
        • Marano M.
        • Capone F.
        • Travaglino F.
        • Antonelli Incalzi R.
        • et al.
        Posterior reversible encephalopathy syndrome and brain haemorrhage as covid-19 complication: a review of the available literature.
        J Neurol. 2021; 268https://doi.org/10.1007/S00415-021-10709-0
        • Yeahia R.
        • Schefflein J.
        • Chiarolanzio P.
        • Rozenstein A.
        • Gomes W.
        • Ali S.
        • Mehta H.
        • Al-Mufti F.
        • McClelland A.
        • Gulko E.
        Brain MRI findings in COVID-19 patients with PRES: a systematic review.
        Clin Imaging. 2022; 81: 107-113https://doi.org/10.1016/J.CLINIMAG.2021.10.003
        • Mansoor T.
        • Alsarah A.A.
        • Mousavi H.
        • Khader Eliyas J.
        • Girotra T.
        • Hussein O.
        COVID-19 associated reversible cerebral vasoconstriction syndrome successfully treated with nimodipine and aspirin.
        J Stroke Cerebrovasc Dis. 2021; 30105822https://doi.org/10.1016/J.JSTROKECEREBROVASDIS.2021.105822
        • Dakay K.
        • Kaur G.
        • Gulko E.
        • Santarelli J.
        • Bowers C.
        • Mayer S.A.
        • Gandhi C.D.
        • Al-Mufti F.
        Reversible cerebral vasoconstriction syndrome and dissection in the setting of COVID-19 infection.
        J Stroke Cerebrovasc Dis. 2020; 29https://doi.org/10.1016/J.JSTROKECEREBROVASDIS.2020.105011
        • Ray S.
        • Kamath V.V.
        • Raju PA.
        • KN R.
        • N S.
        Fulminant reversible cerebral vasoconstriction syndrome in breakthrough covid 19 infection.
        J Stroke Cerebrovasc Dis. 2022; 31https://doi.org/10.1016/J.JSTROKECEREBROVASDIS.2021.106238
        • Arandela K.
        • Samudrala S.
        • Abdalkader M.
        • Anand P.
        • Daneshmand A.
        • Dasenbrock H.
        • Nguyen T.
        • Ong C.
        • Takahashi C.
        • Shulman J.
        • et al.
        Reversible cerebral vasoconstriction syndrome in patients with coronavirus disease: a multicenter case series.
        J Stroke Cerebrovasc Dis. 2021; 30https://doi.org/10.1016/J.JSTROKECEREBROVASDIS.2021.106118